<DOC>
	<DOCNO>NCT01725152</DOCNO>
	<brief_summary>This Phase 2 proof-of-concept study double-blind , randomize , placebo-controlled , crossover study investigate ganaxolone treatment child fragile x syndrome ( FXS ) . Up 60 subject ( age 6-17 yr ) randomize receive either ganaxolone placebo 6 week cross opposite treatment another 6 week . The aim study ass safety , tolerability efficacy ganaxolone treatment anxiety attention subject FXS . The hypothesis ganaxolone treatment compare placebo improve anxiety attention measure several neuropsychological psychometric test .</brief_summary>
	<brief_title>Ganaxolone Treatment Children With Fragile X Syndrome</brief_title>
	<detailed_description>This single center study UC Davis MIND Institute . Children fragile x syndrome age 6-17yrs , inclusive randomize 1:1 ratio receive ganaxolone placebo treatment 6 week , discontinue treatment washout 2 week , cross opposite treatment another 6 week . The primary aim study assess efficacy ganaxolone treatment compare placebo clinical behavior anxiety attention measure Clinician 's Global Impression-Improvement ( CGI-I ) . The key secondary efficacy measure Pediatric Anxiety Scale ( PARS ) . Other secondary efficacy measure include visual analog scale ( VAS ) , Anxiety , Depression , Attention , Mood Scale ( ADAMS ) , Swanson , Nolan , Pelham-IV Questionnaire ( SNAP-IV ) , Aberrant Behavior Checklist- Community Edition ( ABC-C ) . Tolerability safety monitor routine vital sign , physical/neurological exam , ECGs , clinical laboratory adverse event assessment .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<mesh_term>Pregnanolone</mesh_term>
	<criteria>molecular documentation FMR1 full mutation age 617 yr , inclusive sexually active subject require use medically acceptable form birth control nonEnglish Spanish speaking subject concomitant systemic steroid , vigabatrin , felbamate ketoconazole change medication within last 2 month clinically unstable medical disease , progressive CNS disease/disorder history recurrent status epilepticus unwilling withhold grapefruit grapefruit juice duration study actively suicidal</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>fragile x syndrome</keyword>
	<keyword>ganaxolone</keyword>
	<keyword>anxiety</keyword>
	<keyword>attention</keyword>
	<keyword>pediatric</keyword>
</DOC>